INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
RC

Ring Christine

Chief Legal OfficerCIK 0001817199

EDGAR filingsOpen in network
Disclosed transactions46
Buys / sells0 / 14
Max Insider Score35
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
5,786 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Nurix Therapeutics, Inc.Chief Legal Officer · Nov 24, 2025
12
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL
$29K
1,075 sh
Nov 2, 2026
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

3
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$50K
5,786 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

19
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$245K
9,527 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

23
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$158K
6,113 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

10
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

14
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,750 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

10
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

35
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$104K
3,957 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

6
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,573 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

10
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,750 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

10
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,573 sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

0
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
15.6K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC FORM 4

Evidence

7
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$97K
13.3K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC FORM 4

Evidence

7
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$136K
15.6K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC FORM 4

Evidence

21
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$581K
28.9K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC FORM 4

Evidence

0
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
13.3K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC FORM 4

Evidence

15
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$90K
5,394 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC FORM 4

Evidence

6
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,750 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC FORM 4

Evidence

6
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC FORM 4

Evidence

6
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,858 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC FORM 4

Evidence

6
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,858 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC FORM 4

Evidence

31
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$53K
3,214 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC FORM 4

Evidence

2
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC FORM 4

Evidence

10
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,750 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC FORM 4

Evidence

19
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
14.3K sh
Feb 9, 2026Feb 9, 2026
traded Feb 9, 2026
+0dSEC FORM 4

Evidence

5
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

5
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
1,925 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

5
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

9
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,750 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

27
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$1,529
88 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

5
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

9
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,859 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

34
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$72K
4,333 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

5
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
1,925 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

13
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
3,750 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC FORM 4

Evidence

0
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$6,994
3,760 sh
Jan 20, 2026Jan 20, 2026
traded Jan 20, 2026
+0dSEC FORM 4

Evidence

18
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$69K
3,760 sh
Jan 20, 2026Jan 20, 2026
traded Jan 20, 2026
+0dSEC FORM 4

Evidence

7
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
3,760 sh
Jan 20, 2026Jan 20, 2026
traded Jan 20, 2026
+0dSEC FORM 4

Evidence

0
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$6,994
3,760 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC FORM 4

Evidence

8
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
3,560 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC FORM 4

Evidence

1
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,711
200 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC FORM 4

Evidence

3
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
3,760 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC FORM 4

Evidence

19
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$642K
37.6K sh
Nov 24, 2025Nov 24, 2025
traded Nov 24, 2025
+0dSEC FORM 4

Evidence

14
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$70K
37.6K sh
Nov 24, 2025Nov 24, 2025
traded Nov 24, 2025
+0dSEC FORM 4

Evidence

0
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
37.6K sh
Nov 24, 2025Nov 24, 2025
traded Nov 24, 2025
+0dSEC FORM 4

Evidence